GABRIELLE JOHNSON: Open Payments
NPI 1871013748 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,162 in 19 payments from 14 companies in 2025. Trend: 2023 $346 · 2024 $578 · 2025 $1,162
Food & beverage: $984Education: $178
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $163 |
| Astellas Pharma US Inc | 1 | $131 |
| Kite Pharma, Inc. | 1 | $125 |
| Incyte Corporation | 1 | $124 |
| PFIZER INC. | 1 | $117 |
| Daiichi Sankyo Inc. | 2 | $117 |
| AstraZeneca Pharmaceuticals LP | 3 | $106 |
| Karyopharm Therapeutics Inc. | 1 | $91 |
| SEAGEN INC. | 1 | $78 |
| KYOWA KIRIN, INC. | 1 | $29 |
Products named: Vyloy, Yescarta, Niktimvo, ELREXFIO, Enhertu, RYBREVANT, XPOVIO, POTELIGEO.
Industry payments across AZ — which companies pay providers there.
